FDA Inspection 1040454 — Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (API Site)
The FDA completed an inspection of Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (API Site) on Dec 8, 2017 in Lianyungang. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lianyungang (China)